FOXO1 and hepatocellular carcinoma: In this study, we not only verified the above conclusion, but further found that in HCC, miR-96 might activated AKT/GSK-3β/β-catenin signaling pathway and promoted the entry of β-catenin into the nucleus by directly inhibition of FOXO1.